Loading...
Loading...
Glaucoma is a group of progressive optic neuropathies that cause irreversible vision loss through damage to retinal ganglion cells and their axons. It is the leading cause of irreversible blindness worldwide, and a significant portion of people with glaucoma are undiagnosed because the most common form produces no symptoms until substantial vision has already been lost. This makes understanding glaucoma essential for every paraoptometric -- you are often the first person to perform the screening tests that detect it.
A critical concept to grasp from the outset: glaucoma is not simply "high eye pressure." While elevated intraocular pressure (IOP) is the most significant and only modifiable risk factor, the disease is defined by optic nerve damage and visual field loss. Some patients develop glaucoma with completely normal IOP readings, while others maintain elevated IOP for years without any nerve damage. This distinction is tested frequently on both the CPO and CPOA exams.
As a paraoptometric, you perform the core screening and monitoring tests for glaucoma: tonometry, pachymetry, visual field testing, OCT imaging, and fundus photography. Understanding what each test measures, what constitutes an abnormal finding, and when to alert the doctor makes you an invaluable part of the glaucoma care team.
Glaucoma is classified by the mechanism causing damage. The four main categories you should know for the CPO and CPOA exams are primary open-angle, angle-closure, normal-tension, and secondary glaucoma. Each has distinct characteristics, risk profiles, and clinical presentations.
The most common form, accounting for roughly 70-80% of all glaucoma cases. The drainage angle appears open and normal on examination, but aqueous humor outflow is impaired at the microscopic level within the trabecular meshwork. IOP rises gradually and painlessly over months to years. Patients have no symptoms until significant peripheral vision is lost -- this is why glaucoma is called the "silent thief of sight."
POAG is bilateral but often asymmetric. A patient may have more advanced damage in one eye than the other. Risk increases significantly after age 60, in individuals of African American heritage, and in those with a family history of glaucoma.
Occurs when the peripheral iris physically blocks the trabecular meshwork, preventing aqueous drainage. Acute angle closure is an ophthalmic emergency: IOP rises rapidly (often to 40-80 mmHg), causing sudden severe eye pain, headache, nausea and vomiting, halos around lights, blurred vision, and a red eye with a hazy cornea. The pupil is mid-dilated and fixed.
Chronic angle closure is more insidious -- the angle gradually narrows over time, and IOP elevation may be intermittent. Risk factors include hyperopia (short eye with shallow anterior chamber), increasing age, female sex, and East Asian heritage. If you see a patient presenting with acute symptoms, alert the doctor immediately.
The optic nerve sustains glaucomatous damage despite IOP measurements consistently within the statistically normal range (below 21 mmHg). This form accounts for roughly 30-40% of open-angle glaucoma cases and is more common in individuals of Japanese descent and in women.
NTG underscores why IOP alone cannot be used to diagnose or rule out glaucoma. The optic nerve in these patients may be unusually susceptible to pressure-related damage, or vascular insufficiency may contribute. Even though IOP is "normal," lowering it further with treatment slows progression. Disc hemorrhages (small splinter-shaped bleeds at the disc margin) are particularly common in NTG.
Elevated IOP and optic nerve damage caused by another identifiable condition. Common causes include trauma (angle recession glaucoma), inflammation (uveitic glaucoma), corticosteroid use (steroid-induced glaucoma -- can occur with eye drops, oral steroids, or even inhaled/topical steroids), pseudoexfoliation syndrome, and pigment dispersion syndrome. The paraoptometric should always document steroid use in the patient history and note any history of eye trauma or inflammation, as these are relevant to the doctor's assessment.
Understanding glaucoma risk factors helps the paraoptometric identify patients who need closer screening and more frequent monitoring. The CPO and CPOA exams test your knowledge of which factors increase glaucoma risk and why.
The single most important risk factor and the only modifiable one. Every 1 mmHg of IOP reduction decreases glaucoma progression risk by approximately 10%. However, there is no "safe" IOP threshold -- some patients develop damage at 16 mmHg while others tolerate 28 mmHg without damage.
Glaucoma prevalence increases significantly with age. The trabecular meshwork becomes less efficient at draining aqueous over time, and the optic nerve may become more vulnerable to pressure-related damage. Screening should be more vigilant in older patients.
First-degree relatives of glaucoma patients have a 4-9 times higher risk of developing the disease. During patient intake, always ask about family history of glaucoma and document it clearly. This information directly influences the doctor's screening and monitoring decisions.
A central corneal thickness (CCT) below 555 microns is both an independent risk factor for glaucoma and a source of IOP measurement error (thin corneas cause tonometry to underestimate true IOP). Pachymetry should be measured at least once for all glaucoma suspects.
African Americans develop glaucoma at higher rates, at younger ages, and experience more aggressive disease progression compared to other populations. Screening is recommended starting at age 40 (versus 60 for average-risk individuals). This disparity makes early detection particularly important.
High myopia (nearsightedness) increases glaucoma risk. Myopic eyes tend to have larger, more tilted optic discs that can be harder to evaluate for glaucomatous changes, and the lamina cribrosa (the sieve-like structure through which nerve fibers pass) may be structurally weaker.
Intraocular pressure is produced by the continuous secretion of aqueous humor from the ciliary body into the posterior chamber. The aqueous flows through the pupil into the anterior chamber and drains primarily through the trabecular meshwork into Schlemm's canal (the conventional outflow pathway), with a smaller amount draining through the uveoscleral pathway. When outflow is impaired, IOP rises.
Normal IOP is statistically defined as 10-21 mmHg, but this is a population average, not a biological threshold for damage. The concept of "target IOP" is central to glaucoma management: the doctor sets an individualized pressure goal low enough to prevent further damage for that specific patient. Every current glaucoma treatment works by either decreasing aqueous production or increasing aqueous outflow.
Key Exam Concept: IOP Is Not Diagnostic
The CPO and CPOA exams frequently test whether you understand that IOP alone does not diagnose glaucoma. A patient with IOP of 25 mmHg but a healthy optic nerve and normal visual fields has ocular hypertension, not glaucoma. A patient with IOP of 16 mmHg but a damaged optic nerve and arcuate visual field defects has normal-tension glaucoma. Always look at the complete clinical picture.
Paraoptometrics perform the essential screening and monitoring tests that form the foundation of glaucoma care. Understanding what each test measures, how to perform it accurately, and what findings are clinically significant allows you to be an effective member of the care team.
Tonometry (IOP Measurement)
Non-contact tonometry (NCT/air-puff) is commonly used for screening. It is quick and does not require topical anesthetic, but is less precise than Goldmann applanation tonometry (GAT), which is the gold standard. The paraoptometric typically performs NCT and may assist with GAT by instilling anesthetic and fluorescein drops. Always record the time of measurement -- IOP varies throughout the day (diurnal variation), tending to be highest in the morning.
Pachymetry (Corneal Thickness)
Measures central corneal thickness (CCT) using an ultrasonic pachymeter. A single drop of topical anesthetic is instilled, and the probe is gently placed on the central cornea. Multiple readings are taken and averaged. Average CCT is approximately 540-555 microns. Results are used to adjust IOP interpretation: thick corneas overestimate IOP, thin corneas underestimate it.
Visual Field Testing (Perimetry)
Automated perimetry (typically Humphrey Visual Field Analyzer) maps the patient's sensitivity to light at various points in their visual field. The paraoptometric positions the patient, explains the test procedure, selects the appropriate test protocol, and monitors test reliability during the exam. Key reliability indicators: fixation losses should be below 20%, false positives below 15%, and false negatives below 33%. An unreliable field cannot be clinically interpreted.
OCT of RNFL and Optic Nerve
Optical coherence tomography (OCT) provides detailed cross-sectional images of the retinal nerve fiber layer (RNFL) and optic nerve head. The paraoptometric performs the scan by positioning the patient, aligning the instrument, and ensuring adequate signal quality. OCT can detect structural nerve fiber loss before visual field defects appear, making it crucial for early detection. Sectors shown in yellow or red on the printout indicate thinning below normal ranges.
Fundus Photography
Optic disc photographs create a permanent baseline record for comparison over time. The paraoptometric captures clear, centered images of the optic nerve head. Serial photographs are valuable for detecting progressive cup enlargement, rim thinning, and disc hemorrhages that may not be apparent on a single exam.
Gonioscopy Assistance
While the doctor performs gonioscopy (using a mirrored contact lens to view the drainage angle), the paraoptometric assists by preparing the patient, instilling topical anesthetic, and having the gonioscopy lens ready. Understanding angle anatomy and the Shaffer grading system (Grade 0-4) helps the paraoptometric document findings accurately and understand the clinical significance.
Glaucoma damages retinal nerve fibers in predictable patterns based on their anatomical arrangement. The nerve fibers entering the optic disc at the superior and inferior poles are most vulnerable, which produces characteristic visual field defects that the paraoptometric should recognize.
The hallmark glaucomatous defect. A curved band of vision loss following the arcuate nerve fiber bundles above or below fixation. This pattern reflects damage to the nerve fibers entering the superior or inferior poles of the optic disc. May start as isolated clusters of depressed points that coalesce into a complete arc over time.
A step-like defect at the horizontal meridian in the nasal visual field. Because superior and inferior nerve fiber bundles do not cross the horizontal midline, damage to one set creates a defect that respects this boundary, producing a characteristic "step" appearance. Often an early finding.
Small isolated areas of vision loss near fixation (within the central 10 degrees). More common in normal-tension glaucoma. Because these defects are close to central vision, patients may notice them earlier than peripheral defects, but they are also more functionally significant.
In advanced disease, only a small island of central vision remains (sometimes with a temporal crescent). The patient may still read 20/20 on the acuity chart while being functionally disabled -- they cannot navigate safely, drive, or see anything not directly in front of them. This dissociation between acuity and field is a key teaching point.
Patient education is one of the most impactful roles a paraoptometric plays in glaucoma care. Because most glaucoma is painless and asymptomatic, patients often struggle to understand why they need to use drops every day for a disease they cannot feel. Poor compliance with glaucoma medications is a major cause of preventable vision loss.
Help patients understand that glaucoma drops lower IOP to protect the optic nerve. Missing doses allows IOP to rise, which causes cumulative damage over time. The vision lost to glaucoma cannot be restored -- treatment can only preserve what remains. Using drops consistently is like taking blood pressure medication: you don't feel the benefit day-to-day, but it prevents serious consequences long-term.
Patients at risk for angle closure (narrow angles identified on exam) should be educated about warning signs: sudden severe eye pain, headache, nausea, halos around lights, and blurred vision. If these occur, they should seek immediate emergency eye care -- not wait for a scheduled appointment. Permanent vision loss can occur within hours.
Many patients waste medication or reduce its effectiveness with poor technique. Teach punctal occlusion (pressing gently on the inner corner of the eye for 1-2 minutes after instilling drops) to reduce systemic absorption and increase ocular contact time. Ensure the patient understands to wait 5 minutes between different drops. Verify they are not using expired medication.
Recognizing Acute Angle-Closure: An Emergency
If a patient presents with a red, painful eye with decreased vision, nausea, halos around lights, and a mid-dilated pupil that is fixed (does not react to light), suspect acute angle-closure glaucoma and alert the doctor immediately. The cornea may appear hazy or cloudy due to edema from the extreme IOP elevation. Do not proceed with routine testing -- this patient needs urgent medical intervention. IOP in acute angle closure can exceed 60-80 mmHg, and permanent optic nerve damage can occur within hours.
Technique, accuracy, and clinical role of air-puff tonometry in IOP screening.
Perimetry technique, reliability indices, and interpreting common defect patterns.
How CCT affects IOP interpretation and glaucoma risk assessment.
Browse all CPO and CPOA study topics organized by category.
No. Glaucoma is a progressive optic neuropathy -- damage to the optic nerve -- that causes characteristic visual field loss. Elevated intraocular pressure (IOP) is the most important risk factor and the only modifiable one, but it is not the disease itself. Some patients develop glaucomatous damage with normal IOP (normal-tension glaucoma), while others have elevated IOP for years without ever developing nerve damage (ocular hypertension). The diagnosis requires evidence of optic nerve damage, typically confirmed by structural changes on exam or OCT and functional changes on visual field testing.
Acute angle-closure glaucoma is an ophthalmic emergency. The classic presentation includes sudden severe eye pain, headache, nausea and vomiting, halos around lights, a red eye, a hazy or cloudy cornea, and a mid-dilated pupil that is poorly reactive to light. IOP is extremely elevated, often 40-80 mmHg. If a patient presents with these symptoms, the paraoptometric should immediately alert the doctor. Permanent vision loss can occur within hours without treatment.
Central corneal thickness (CCT) directly affects the accuracy of IOP measurements. A thicker-than-average cornea (above 555 microns) causes tonometry to overestimate IOP, while a thinner-than-average cornea (below 555 microns) causes underestimation. This means a patient with thin corneas may have a true IOP that is significantly higher than what the tonometer reads, which can delay detection of elevated pressure. Thin CCT is also an independent risk factor for glaucoma progression. Pachymetry should be performed at least once as a baseline in all glaucoma suspects.
Target IOP is the pressure level the doctor determines is low enough to prevent further optic nerve damage in a specific patient. It is not a single number for everyone -- it depends on the severity of damage, the patient's baseline IOP, risk factors, and life expectancy. For example, a patient with severe damage and an IOP of 28 mmHg might need a target of 12 mmHg (a 57% reduction), while a patient with mild damage and IOP of 24 mmHg might have a target of 18 mmHg. Paraoptometrics should understand this concept to support patient education about why consistent use of drops matters.
Glaucoma preferentially damages nerve fibers entering the optic disc at the superior and inferior poles, producing visual field defects that follow the arcuate nerve fiber bundles. Early defects include paracentral scotomas (small blind spots near fixation), nasal steps (defects respecting the horizontal midline), and arcuate scotomas (curved areas of loss above or below fixation). As damage progresses, these defects enlarge and can merge into ring scotomas. Late-stage glaucoma leaves only a small central island of vision. Importantly, patients often do not notice peripheral vision loss until it is advanced, which is why screening is critical.
Monitoring frequency depends on disease severity and stability. Newly diagnosed or unstable patients may be seen every 1-3 months until IOP is at target. Stable patients are typically seen every 3-6 months for IOP checks and annually for comprehensive testing including visual fields and OCT. Glaucoma suspects (elevated IOP or suspicious disc without confirmed damage) are usually monitored every 6-12 months. The paraoptometric plays a key role in scheduling appropriate follow-up intervals and reminding patients about the importance of keeping appointments.